AstraZeneca AB
What science can do

AstraZeneca (AZ) is a global, innovation and research-driven biopharmaceutical business that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of cardiovascular, metabolic, renal, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases.

AstraZeneca operates in over 100 countries. The innovative portfolio
of medicines of AstraZeneca are used by millions of patients worldwide.

Our tasks
in the project
AZ will be active in several sections within the project: WP2-Engagement (ensure patient voice & multi-stakeholder engagement), WP6- Evaluation (to validate that the project promise is delivered), and WP7-Sustainability (to ensure a viable future for the project solutions).

Our contribution to the project

AZ will bring broad therapeutic area expertise as well as expertise in drug development with specialized knowledge and experience in patient safety. The AZ representatives will offer their extensive experience working with leading experts in their respective areas from health authorities, academia and industry and as such can bring to this project. a well-informed perspective.

We are a global, innovation-driven biopharmaceutical business. We push the boundaries of science to deliver medicines that transform the lives of people around the world.

AstraZeneca, Science newsreel

Address: Cambridge, Cambridgeshire, UK